SurgLine International, Inc. (SGLN)
- Previous Close
0.0000 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0000 - Volume
6,666 - Avg. Volume
53,333 - Market Cap (intraday)
22,760 - Beta (5Y Monthly) -38.84
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0010 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Surgline International, Inc. sources and sells medical and surgical products. It offers a range of surgical instruments, including scissors, forceps, basket punches, reamers, and pulse lavages. The company also provides surgical sets, such as hand and foot, and hips and small fragments; spine products consisting of ALIF systems, anterior cervical plates, PLIF systems, TLIF systems, cervical PEEK IBFDs, and pedicle screw systems; drill system and power tools comprising cordless and pneumatic drills, chucks, sleeves, saws, hoes, charges, and batteries. In addition, it offers emergency removal devices for broken screws and implant removal; a range of endoscopes; surgical burs and blades; and medical, surgical, and dental disposables. The company sells its products under the Surg brand. It serves acute care hospitals, ambulatory surgery centers, physicians, dentists, urgent care centers, and insurers, as well as others. The company was formerly known as China Nuvo Solar Energy, Inc. and changed its name to Surgline International, Inc. in October 2011. Surgline International, Inc. is based in West Palm Beach, Florida.
--
Full Time Employees
July 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: SGLN
Trailing total returns as of 4/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGLN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGLN
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1,462.95%
Return on Equity (ttm)
--
Revenue (ttm)
113.62k
Net Income Avi to Common (ttm)
-2.74M
Diluted EPS (ttm)
-0.0010
Balance Sheet and Cash Flow
Total Cash (mrq)
7.47k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.49M
Company Insights: SGLN
SGLN does not have Company Insights